Senate Finance Committee Chair Ron Wyden, D-Ore., this week asked the Biden administration to share key information with the public about the implementation of the Inflation Reduction Act’s drug pricing provisions. “The Finance Committee will be paying close attention to how the inflation rebate provisions work to lower prices for seniors and hold manufacturers accountable if they continue to raise prices beyond the rate of inflation,” Wyden wrote. “The information requested is critical to ensuring that Medicare beneficiaries understand the broad reach of the IRA and the inflation rebate provisions that intend to protect them.”
The letter, sent to Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure, comes as drug companies announced price increases on at least 872 drugs since January 1. In a recent report from the Department of Health and Human Services (HHS), more than 3,000 drugs saw a price increases in 2022. Between July 2021 and July 2022, price increases on 1,216 drugs outpaced inflation, with an average price increase of 32 percent.
The letter asks CMS to publicize details on how these provisions will be implemented, including a distinct timeline for the Part B and Part inflation rebates, as well as clear information to understand how the inflation rebates will be calculated and collected.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.